EVR RX LDN?

Based on the most helpful WSO content, there isn't specific information available about the EVR RX group in London (LDN) for 2025. However, here are some general insights about Evercore's RX division that might help:

1. Compensation: Evercore RX roles are known for offering competitive pay, often surpassing M&A roles at times. For example, first-year associates in RX at independent advisory shops like EVR can earn up to $250-300k all-in. Analyst compensation in 2023 was around $168k for first-year analysts, which aligns with other elite boutiques.

2. Culture: The culture at Evercore has been described as intense, with some groups experiencing "sweaty" dynamics and infighting as the firm has grown. RX teams, being smaller, might have a more cohesive environment, but this can vary by location and leadership.

3. Hours: RX hours are often described as brutal, sometimes worse than M&A. Anecdotes suggest RX analysts at Evercore work longer hours than their M&A counterparts, with earlier starts and later finishes.

4. Deal Flow: Evercore RX is highly regarded, especially in the U.S., where it competes with top players like HL, PJT, and Lazard. The group focuses on debtor-side mandates and has a strong reputation for analyst placement into distressed funds and special situations groups. However, the London group is noted to be smaller, which could mean fewer deals but potentially more exposure per deal.

If you're looking for specifics about the London group in 2025, it might be worth reaching out to current analysts or alumni for the most up-to-date insights.

Sources: EVR RX v.s. HL NYC RX, Evercore paying up to $25,000 to delay start date, Evercore paying up to $25,000 to delay start date, EB Comparisons, Pros & Cons Summary - Post-MBAs in Restructuring (RX) - any regrets?